Arrhythmias & electrophysiology

From Paroxysmal to Persistent Atrial Fibrillation: Progressive Fibrosis of the Left Atrial Posterior Wall

JACC Cardiovasc ImagingPublished Prospective cohort study

Authors' conclusion

LAPW fibrosis may be an important factor in the progression from PAF to PsAF.

Study context

Population
Patients with atrial fibrillation (AF) and healthy volunteers undergoing 18F-AlF-FAPI PET-MRI; separate cardiac surgery cohort with biopsy78 AF, 49 healthy volunteers
Exposure
FAPI-PET-MRI atrial fibrosis across AF stages vs healthy volunteers
  • Healthy volunteersn = 49reference
Outcome
Level of atrial fibrosis (fibroblast activation protein inhibitor (FAPI) positive ratio) in different stages of AF
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Fibrosis positive ratio
Positive ratio significantly higher in PsAF and PmAF vs PAF and healthy volunteers across all atrial regions
P < 0.05

Observational data: associations, not effects.

Further findings

Discrimination of AF stage by positive ratio

AUC PAF vs PsAF, LA (cutoff 0.072)
0.991
AUC PAF vs PsAF, left atrium posterior wall (LAPW) (cutoff 0.025)
0.983
AUC PsAF vs PmAF, LA (cutoff 0.382)
0.756

Histology (36 surgical patients, 124 tissue fragments)

Increased fibrotic deposition in regions with increased 18F-FAPI uptake

Original publication

From Paroxysmal to Persistent Atrial Fibrillation: Progressive Fibrosis of the Left Atrial Posterior Wall. JACC Cardiovasc Imaging. Published 25 June 2025. doi:10.1016/j.jcmg.2025.03.013

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.